In a featured article published in Frontiers in Science, MBIM professor Robert Hancock and coauthors describe how a bioinformatic systems immunology approach can transform the diagnosis and treatment of sepsis.
Dane Sands and Xianya Qu Awarded the 2024-25 Zymeworks Fellowships
We are excited to extend our congratulations to Dane Sands and Xianya Qu, the 2024-25 recipients of the Zymeworks Fellowship in Advanced Protein Therapeutics.
Kronstad lab uncovering weaknesses for the fungal cause of cryptococcosis
Kronstad lab studies Cryptococcus neoformans, a deadly fungal pathogen in immunocompromised people. They've found key virulence factors and potential drug targets.
New Compound Shows Promise for Treating Tuberculosis
A new study from the Sun Lab (MBIM), co-led by PhD student Yichu Liang, presents SMIP-031, a novel compound enhancing immune response to treat tuberculosis (TB).